- Net Income: Zhejiang Juhua reported a net income of 423.3 million yuan for the third quarter.
- Revenue: The company’s revenue for the same period was 5.83 billion yuan.
- Analyst Ratings: The stock has strong market confidence with 20 buy ratings, and no hold or sell ratings from analysts.
A look at Zhejiang Juhua Co A Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 3 | |
Dividend | 2 | |
Growth | 5 | |
Resilience | 3 | |
Momentum | 2 | |
OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Looking at the Smartkarma Smart Scores for Zhejiang Juhua Co A, it appears the company holds a promising long-term outlook. With a strong score in Growth, Zhejiang Juhua Co A is positioned well for expansion and development within its industry. Additionally, its Value and Resilience scores indicate a solid foundation for financial stability and enduring performance in the market. While its Dividend and Momentum scores are slightly lower, the overall outlook remains positive for Zhejiang Juhua Co A as it continues to grow and adapt.
Zhejiang Juhua Co A, a company specializing in chemical products, demonstrates potential for future growth and sustainability based on the Smartkarma Smart Scores analysis. With a diverse range of products including alkali, fluoride, ammonia, and bio-chemicals, Zhejiang Juhua Co A is well-positioned to capitalize on the opportunities presented in the chemical industry. By focusing on enhancing its value, resilience, and growth prospects, Zhejiang Juhua Co A sets a solid foundation for long-term success and market competitiveness.
Summary of the Zhejiang Juhua Co. Ltd.: Zhejiang Juhua Co. Ltd. manufactures and markets chemical products. The Company’s products include alkali products, fluoride products, ammonia products, acid products, pesticides, biochemicals, and other chemical products.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars